In recent years, next-generation sequencing has allowed physicians and researchers alike to gather more genetic data for patients with gastrointestinal cancers. And while this kind of profiling continues to advance, so do treatment options for this patient population.
Many people don't realize they are putting pressure on those walking though cancer to keep a good attitude. There are days we all need to be able to acknowledge that it can be difficult.
The FDA approved a new combination for patients with newly-diagnosed low-risk acute promyelocytic leukemia (APL).
When we are in situations in which others will see our cancer scars, do we have to explain them or worry about what someone else thinks?
Cancer isn't only a horrible disease, she's a great teacher. Here are some of the lessons she's taught me along my journey.
January is Cervical Health Awareness Month. Learn how women with cervical cancer can manage potential fertility concerns.
Breast cancer survivor tries to make rational choices based on newer genetic testing results.
A recurrence is always a possibility for any victim of cancer, but should survivors expect a recurrence? If so, how can they prepare for that possibility?
The Food and Drug Administration (FDA) expanded the approved use for Gilotrif (afatinib). The drug can now be used to treat patients with metastatic non-small cell lung cancer (NSCLC) who have uncommon EGFR alterations in L861Q, G719X and/or S768I.
Kevin explains the delights of being both a cancer patient and an adult.
Traditionally, desmoplastic melanoma was difficult to treat because the tumor tissue is so dense. However, researchers just discovered that immunotherapy agents have potential in this space.
A male breast cancer survivor offers some alternatives to stress.
Using the generic skin cream fluorouacil 5 percent (5-FU) for two to four weeks may reduce the risk for squamous cell carcinoma (SCC) for up to a year, according to a study published in JAMA Dermatology.
I feel like the Giving Tree. I like to give, but some of my energy and ability to assist were taken away, not by a boy, but by a disease with consequences.
As a cancer survivor, reading some information brings an uneasy feeling.
Lynparza (olaparib) was granted approval by the Food and Drug Administration (FDA) for the treatment of patients with BRCA-positive, HER2-negative metastatic breast cancer who have previously received chemotherapy. Also, patients who have HR-positive disease should have prior endocrine therapy or they would not be considered appropriate for such treatment.
"Garden variety" breast cancer is no longer the norm thanks to the discovery of more genetic mutations.
"Breathe in God, breathe out cancer," I prayed with as much conviction as I could muster.
Those of us who had chemotherapy and/or radiation as part of our treatment have now been hit with another lovely late effect, if the results of a new study are accurate. We have the potential to age prematurely.
With wit and wisdom, Carolyn Choate recounts the resilience of cancer survivors everywhere to outwit the enemy within.
Parts of the Northeast had a foot or more of snow last week. What should patients do when their scheduled cancer treatment falls in the middle of a snow storm?
